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1. Introduction 
The soybean plant (Glycine max L) belongs to the family Leguminosae (Order Rosacea) and 
probably originated from China, 4000 to 5000 years ago. It was introduced in Europe circa 
1700 and today is one of the world’s most important crops. It is an important plant for 
human and animal nutrition as well as for industrial purposes because about 60% of the 
world’s processed food products contain ingredients derived from soy (Liu, 1999; Friedman 
& Brandom, 2001; Soares et al., 2005; Priolli et al., 2002). 
Soybean is an almost unique food because of its protein, mineral and fiber content. In the 
plant kingdom it has the highest content of phytochemicals (such as flavones), which are 
compounds whose structure closely resembles that of estrogen, suggesting that it could 
exert similar activities (Lissin & Cooke, 2000; Mateos-Aparicio et al., 2008). 
The processing cost of soybean oil is very low. In addition to oil, soybeans are processed into 
many foods and food additives such as lecithin (Gesteira et al., 2003; Mateos-Aparicio et al., 
2008). Lecithin is widely used as a functional food and for industrial applications due to its 
emulsifying properties (Awazuhara et al., 1998; Taylor & Kabourek, 2003). 
The soybean plant has oblong pods with 2 to 4 seeds containing approximately 38% protein, 
18% oil, 30% carbohydrates, 14% moisture, ash, and secondary components and it is an 
important source of vitamins (A, thiamin, riboflavin, pyridoxine and folic acid) and minerals 
(Fe, Zn, Mg, K, Ca, Mn, and Se), phytoestrogens and fibers (Liu; 1997b; Anderson et al., 
1995; Soares et al., 2005; Reynolds et al., 2006). 
Soy concentrates and isolates provide highly concentrated protein sources, high lysine 
content, a bland flavor, and reduction in flatulence factors and reducing sugars, and they 
may improve the overall quality of products (Singh et al, 2008). Soy protein is low in 
viscosity; therefore, it can be used in beverage applications (Xie & Hettiarachchy, 1997; 
Jasentuliyana et al., 1998), helping to achieve the desired mouth-feel. The viscosity promoted 
by soy isolate makes it ideal for other nutritious liquid products such as infant formulas, 
creamers, milk replacers, and spray-dried products (Yao et al., 1988; Riaz, 1999).  Textured 
soy flour is also known as TPS (textured soy protein) or TVP (textured vegetable protein) 
(Endres, 2001).  Textured protein products are prepared commercially by thermoplastic 
extrusion of flours, grits, and protein concentrates under heat and pressure to form chips, 
chunks, flakes, and a variety of other shapes (Singh et al, 2008; Mesa et al., 2009). TPSs are 
frequently made to resemble beef, pork, seafood, or poultry in structure and appearance 
when hydrated (Endres, 2001; Macedo-Silva et al., 2001). 
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Despite its advantages, the soybean possesses antinutritional factors such as protease 
inhibitors, which inhibit proteolytic enzymes and decrease food digestion. These factors can 
reduce the bioavailability of the proteins ingested by the organism (Miura et al., 2001; 
Moughan, 2003; Monteiro et al., 2003). 
Soybeans and soy foods have been recognized for their low fats and good quality protein. 
The soybean proteins, fibers and phytoestrogens are known to decrease cholesterol levels 
and to produce positive effects in reducing chronic disease risk such as diabetes, obesity and 
vascular diseases (Allison et al., 2003; Martin et al., 2008; Jimenez-Escrig et al., 2008; 
Messina, 2010; Chen et al., 2010; Kang et al, 2010).  Since the 1960s, soybean protein products 
have been used as nutritional or functional food ingredients in every food group available to 
the consumer (Endres, 2001).  In Asia, soy proteins have been used for human consumption 
for centuries, during which various unique soy protein foods have been established. 
Onuegbu et al. (2011) studied the effect of soymilk on the lipid and lipoprotein profile of 
normocholesterolemic men and found that the consumption of 500 mL of this drink can 
decrease cholesterol and triglycerides levels and increase HDL-c levels. 
Bansai & Parle (2010) observed that, due to its proestrogenic, antioxidant and 
neuroprotective properties, soybeans can be used as a remedy to improve memory and to 
manage cognitive deficits.  Moreover, soy and soy products provide an alternative source of 
protein for people with cow milk protein intolerance (Riaz, 1999; Dupont et al., 2010) and an 
alternative to the use of probiotics.  Supplementation with prebiotics enhances the potential 
of soymilk as a carrier for probiotics (Yeo & Liong, 2010).  
2. Protein composition 
Proteins are essential for the growth and maintenance of corporal structures. Vegetable 
proteins usually affect protein nutrition because they are not complete in essential amino 
acids, thus reducing the quality of the protein. Animal proteins are considered complete 
because they contain all the amino acids required to produce the human body proteins 
(Martínez Augustin & Martínez de Victoria, 2006). 
The protein content of soybean is about 40% and it is equivalent to animal proteins. Soybean 
has a protein content of about 40%, which is equivalent to animal proteins. The most 
significant limiting amino acids are methionine (10mg/g protein) and cystine (25.00), which 
are sulfur-containing amino acids, but soy is rich in lysine (68.37g/mg protein) (Chung et 
al., 1996; Sacks et al., 2006; Mateos-Aparicio et al., 2008).  Liu (1997b) reported that soybean 
has the following amino acids content in milligrams per gram of protein:  arginine (77.16), 
alanine (40.23), aspartic acid (68.86), glutamic acid (190.16), glycine (36.72), histidine (34.38), 
isoleucine (51.58), leucine (81.69), lysine (68.37), phenylalanine (56.29), proline (52.92), serine 
(54.05), threonine (41.94), tryptophan (12.73), tyrosine (41.55) and valine (41.55). 
The presence of antinutritional factors such as proteolytic enzymes, trypsin inhibitors, 
phenolic compounds and phytic acid can reduce the quality of proteins and their use in the 
organism (Liu, 1999; Monteiro et al., 2003).  
Animal proteins are almost always related to high levels of saturated fats.  This is not the 
case of soy proteins, which are rich in essential amino acids, making them suitable to 
substitute animal protein sources. Soy proteins can also partly replace other sources of 
calories such as fats and carbohydrates (Sacks et al., 2006; Mateos-Aparicio et al., 2008).   
Soy protein ingredients are used in compound foods for their functional properties, 
including water and fat absorption, emulsification, aeration (whipping) and heat setting and 
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for increasing total protein content and improving the essential amino acids profile 
(Jasentuliyana et al., 1998). 
2.1 Soy protein and health 
The high content of fats in the proteins of several animal species can be implicated in the 
increase of blood cholesterol, triglycerides and LDL-c (low density lipoprotein). The 
widespread concern about vascular disease (associated with the daily ingestion of fats and 
sugars) has motivated numerous studies on soybean protein (Allison et al., 2003; Sacks et al., 
2006; Martin et al., 2008; Messina, 2010; Bermudez et al., 2010). Maki et al. (2010) studied the 
effects of the consumption of soy protein on subjects with hypercholesterolemia and 
concluded that it can reduce total blood cholesterol, LDL-c and triglycerides levels. Lerman 
et al. (2010) studied the effects of a diet containing soy protein and sterols in adults with 
metabolic syndrome and observed improvements in their total levels of cholesterol, LDL-c 
and triglycerides, as well as HDL-c.  Metabolic syndrome can be characterized by low HDL-
c and high total cholesterol and triglycerides and is associated with increased risk of 
cardiovascular disease and death, which is significantly increased when accompanied by 
elevated low-density lipoprotein cholesterol (LDL-c). Their study led these authors to 
conclude that individuals at high cardiovascular risk benefit from a soy/phytosterol-
containing medical food. In addition, Torre-Villalvazo et al. (2009) showed that dietary soy 
protein can reduce the ceramide concentration in the heart and may be considered a dietary 
therapeutic approach for the prevention of lipotoxic cardiomyopathy. 
Because of its protein content, soy has gained attention for its potential role in improving 
risk factors for cardiovascular disease, which is one of the leading causes of death 
worldwide. In 1999, the FDA (US Food and Drug Administration) approved labeling for 
foods containing soy protein as a protection against coronary heart disease. Soybean’s 
potential to reduce total cholesterol and LDL-c and increase HDL-c (high density 
lipoprotein) was observed in epidemiological studies on diet and vascular disease in Japan 
and other Asian countries that consume large amounts of soybeans. These studies revealed 
that these countries had lower heart disease rates (Reinolds et al., 2006; Lukaczer et al., 2006; 
Hirayama et al., 2010). 
Soy proteins can also produce beneficial effects on the activity of the angiotensin converting 
enzyme (ACE). They act as ACE inhibitor peptides that can be released enzymatically from 
precursor proteins in vitro during food processing and in vivo during gastrointestinal 
digestion. These peptides can reduce blood pressure by limiting the vasoconstrictive effects 
of angiotensin II and potentiating the vasodilatory effects of bradykinin (De Leo et al., 2009). 
Results of epidemiological and animal studies suggest that consuming soy-containing diets 
reduces the incidence of certain types of cancer. Some authors have shown that soy protein 
isolate may protect against cancer via multiple mechanisms, including: 1) increased 
mammary gland differentiation, 2) decreased activation of procarcinogens to carcinogens, 
and 3) regulation of genes in signal transduction pathways underlying tumor initiation, 
promotion and/or progression (Badger et al, 2005).  
Proteins have a higher satiety power than carbohydrates and fats. Studies suggest that this 
effect can be attributed to a higher thermogenic response of protein. Soy protein may have 
an important effect on postprandial energy expenditure compared to animal protein 
preparations and this can reduce ingestion and obesity, which is a risk factor for heart 
disease (Jequier, 2002; Paddon-Jones et al., 2008; Alfenas et al., 2010).  
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Trevisan et al. (2010) showed that the ingestion of soy protein can help increase the resting 
energy expenditure of post-menopausal women who practice exercises. 
3. Carbohydrate composition 
Soybeans are also rich in carbohydrates, which represent approximately 35% of their 
compounds. They contain about 1% of starch and non-starch polysaccharides such as 
cellulose, hemicelluloses and pectic polysaccharides. Their main sugars are arabinose, 
galactose, uronic acids and glucose (cellulose) (Sosulsk et al., 1982; Wilcox & Shibles, 2001; 
Espinosa-Martos & Ruperes, 2006; Redondo-Cuenca et al., 2007). 
3.1 Soy carbohydrates and health 
Soybeans are a rich source of raffinose, a family of oligosaccharides such as ┙-galactosides 
or galactooligosaccharides, which are non-digestible carbohydrates. Human beings do not 
have ┙-galactosidase, which is needed to hydrolyze these molecules, so they cannot be 
digested.  These molecules are digested by beneficial bifidogenic microorganisms which 
produce gases and short chain fatty acids that have prebiotic activity (functional effects). 
Soybeans also contain sucrose in the form of low amounts of the monosaccharides fructose, 
rhamnose and arabinose. Significant levels of glucose occur only in immature seeds. Non-
digestible oligosaccharides, one of the most popular components of functional food, are 
related to many health benefits (Tomomatsu; 1994; Crittenden & Playne, 1996; Torres y 
Torres et al., 2006).  Monosaccharides such as glucose and arabinose, and measurable 
amounts of di- and oligosaccharides with sucrose, raffinose, and stachyose can be found in 
soybean soluble carbohydrates (Liu, 1999; Sosulski et al., 1982; Huisman, 2000; Mateos-
Aparicio et al., 2008). 
The amount of fibers in soybean can reduce blood cholesterol levels and insulin resistance in 
diabetics. These effects can reduce the incidence of cardiovascular disease and death 
(Chandalia et al., 2000; Redondo-Cuenca et al., 2007; Reynolds et al., 2006; Chen et al., 2010).  
Fibers in diet can also produce anti-inflammatory and anti-carcinogenic effects (Scheppach 
et al., 2004).  
4. Lipids composition 
Liu (1999) found that soybean contains about 22% of oil. The fractions contain triglycerides 
(about 99%) and other components such as phospholipids, unsaponifiable matter 
(tocopherols, phytosterols and carbohydrates) and free fatty acids (Mateo-Aparicio et al., 
2008). 
Soybean contains high percentages of functional polyunsaturated fatty acids, as well as 54% 
linoleic acid and 4-5% linolenic acid, considerable percentages of oleic acid (22-25%) and 
moderate percentages of saturated fatty acids such as palmitic (11%) and stearic acids (4%).  
The predominant fatty acid in soybeans is linoleic acid, which accounts for approximately 
54% of their total fatty acid content (Martins et al., 2003). There are few good sources of -3 
fatty acids such as linolenic acid. Available data suggest that many people have a diet poor 
in this acid; hence, soybeans could be a good source to increase the intake of linolenic acid 
(Messina, 1997; Martin et al., 2008). 
Refined soybean oil is the most widely consumed cooking oil in many countries. Its refining 
process includes degumming, neutralization, bleaching and deodorization steps. The 
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isomerization reactions carried out during these steps may reduce alpha-linolenic acid levels 
significantly. The high temperatures employed in processing increase the rate of 
isomerization reactions, giving rise to increased trans fatty acid levels that may vary from 0.8 
to 2.6% of the product’s total fatty acids and comprise 18:1, 18:2, and 18:3 isomers (Martin et 
al., 2008).  
Trans isomers of monounsaturated and polyunsaturated fat acids are implicated in negative 
effects on human health, such as reduction of cell membrane fluidity, increase in LDL-c and 
decrease in HDL-c levels, modifications in prostaglandin metabolism, and changes in 
platelet aggregation and vascular function. Many authors have demonstrated that the 
consumption of trans fats from partially hydrogenated fats may be associated with the 
development of coronary heart disease (Valenzuela & Morgado, 1999; Oomen et al., 2001; 
Fernandez-San, 2009). 
4.1 Soy lipids and health 
The functional and nutritional value of vegetable oils is based in their fatty acid 
composition. Linolenic acid, with three double bonds, is extremely susceptible to oxidation 
(Gesteira et al., 2003).  Omega polyunsaturated fatty acids are well known for their role in 
many physiological functions and seem to reduce risks of cardiovascular diseases. Several 
mechanisms have been proposed to explain the cardioprotective effect of W-3 PUF, 
including antiarrhythmic, hypolipidemic, and antithrombotic roles (Harper & Jacobson, 
2001; Holguin et al., 2004). These fatty acids may also have beneficial effects on pancreatitis, 
arthritis, allergy and inflammatory diseases (Seki et al., 2010; Lund et al., 2010; Persson & 
Uller, 2010). They can modulate the anti-inflammatory process inside the blood vessels, 
changing the composition of the atherosclerotic plaque and reducing its rupture, which 
precedes infarction (Tull et al., 2009). 
Burghardt et al. (2010) demonstrated the effects of dietary ratios of omega-3 (n-3) to omega-6 
(n-6) polyunsaturated fatty acids (PUFAs) in controlling the markers of metabolic 
syndrome, including insulin sensitivity, inflammation, lipid profiles and adiposity. N-3 
polyunsaturated fatty acids (n-3 PUFAs) reduce plasma triacylglycerols and improve the 
lipoprotein profile by decreasing the fraction of atherogenic small dense LDL (Carpentier et 
al., 2006) and serum cholesterol levels (Chandrashekar et al., 2010). High stearic acid 
soybean oil is a trans-free, oxidatively stable, non-LDL-cholesterol-raising oil that can be 
used to replace trans fatty acids in solid fat applications. In comparison with other saturated 
fatty acids, stearic acid lowers LDL cholesterol and is neutral with respect to HDL 
cholesterol (Hunter et al., 2010). Lemke et al. (2010) showed that stearidonic acid-enriched 
soybean oil increases the omega-3 index by raising erythrocyte eicosapentaenoic acid 
concentrations, suggesting that it may contribute to cardiovascular protective effects. 
Studies correlate the role of n-3 PUFA in the beneficial effects on obesity, insulin resistance 
and secretion of bioactive adipokines including leptin, adiponectin and visfatin (Moreno-
Aliaga et al., 2010). 
Omega-3 fatty acids seem to have a small, dose-dependent hypotensive effect, the extent of 
which seems to be dependent on the degree of hypertension, with a greater effect in 
hypertensive patients and those with high-normal blood pressure (Kris-Etherton et al., 2003; 
Mori, 2010). 
Supplementation of human diets with omega-3 fatty acids reduced several aspects of 
neutrophil, monocyte, and lymphocyte functions, including the production of inflammatory 
mediators (Kelley, 2001). N-3 PUFAs inhibit inflammatory signaling pathways (nuclear 
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factor-kappa B activity), down-regulate fatty acid (FA) synthesis and gene expression (sterol 
regulatory element binding protein-1c) and up-regulate gene expression involved in FA 
oxidation (peroxisome proliferator-activated receptor alpha) (Adkins & Kellen, 2010). 
5. Isoflavones 
Isoflavones, which are phenolic compounds that belong to the phytochemicals, are called 
phytoestrogens in soybeans because they exhibit estrogenic effects. They belong to a group 
called flavonoids, whose structure consists of a flavone nucleus with two benzene rings 
linked to heterocyclic pyrane. In the plant kingdom, soy contains the largest amount of 
isoflavones (Setchell & Cassidy, 1999; Carrão-Panizzi et al., 2002; Cederroth & Nef, 2009).  
The chemical structure of these phenolic compounds is similar to that of cholesterol except 
for the presence of an extra methyl or ethyl group. However, plant sterols are much less 
absorbed in humans than cholesterol (Abumweis & Jone, 2008).  Isoflavones are found 
mostly in soybeans in the form of ß-glucoside conjugates, which include daidzin, genistin, 
glycitin and their malonyl and acetyl derivatives. Genistein and daidzein are the primary 
isoflavones in soybean. Isoflavone glucosides, which are hydrolyzed by intestinal microflora 
glycosidases, are released in the form of daidzein, genistein and glycitein aglucones: the b-
glycosides daidzin, genistin, and glycitin; the acetyl-b-glycosides 6''-O-acetyl-b-daidzin, 6''-
O-acetyl-b-genistin, 6''-O-acetyl-b-glycitin; and the malonyl-b-glycosides 6''-O-malonyl-b-
daidzin, 6''-O-malonyl-b-genistin, and 6''-O-malonyl-b-glycitin (Genoveze et al., 2006; 
Torrezan et al., 2008).  Isoflavones are non-nutritive substances that may be related to 
beneficial health effects (Sacks et al., 2006; Carrara et al., 2009). 
Soybeans are known to be rich in isoflavones, making them important components of 
human diet. The content of these compounds in different cultivars and different soy 
products may be variable.  However, studies have shown that soybean processing causes a 
loss of isoflavones, e.g., in tofu: a 38% loss in normal soybean tofu, 31% in bleached soybean 
tofu, and 56% in lipoxygenase-free tofu (Ciabotti et al., 2006; Mateos-Aparicio et al., 2008). 
5.1 Soy isoflavones and health 
The use of soybeans in human diet can be associated with  a reduction in health problems 
involving the risk of several chronic diseases such as diabetes, obesity, coronary heart 
disease, osteoporosis, and breast and prostate cancer (Brouns, 2002; Jenkins et al., 2003; 
Sacks et al., 2006; Mateos-Aparicio et al., 2008; Rajasree et al., 2009; Dong & Qin, 2011). 
5.1.1 Soy isoflavones and menopause 
Soy is widely employed to treat menopausal symptoms and its use has been studied in 
cross-cultural comparisons. These studies have shown that women living in countries where 
large amounts of soy are normally consumed (e.g., Japan) have fewer menopausal 
symptoms and lower rates of coronary heart disease, fractures, and uterine or breast cancer 
than women living in countries where soy is not part of the normal diet (e.g., the United 
States and Western Europe) (Adlercreutz et al., 1992; Oddens, 1994; Vitolins et al., 2010; Cho 
et al., 2010). 
Soybean isoflavones are believed to be beneficial for menopausal women because this phase 
is characterized by suppression of ovarian function and decreased estrogen secretion, with 
consequent morphological and metabolic disorders resulting from hormonal decline 
(Setchell & Cassidy, 1999; Kang et al., 2010). 
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The daily ingestion of soybean and its isoflavones reduces the frequency of hot flashes. It is 
possible that these isoflavones can bind to free estrogen receptors and produce a weak 
estrogenic effect. This could be useful as a dietary alternative or supplement in 
postmenopausal hormone replacement therapy (Cancelo-Hidalgo & Castelo-Branco, 2010). 
The consumption of soybean isoflavones can also improve lipid profiles in postmenopausal 
women and contribute to reduce the risk of coronary heart disease (Merz-Demlow et al., 
2000; Wangen et al., 2001; Nikander et al., 2004).    Carmignani et al. (2010) evaluated the 
effects of dietary soy supplementation and concluded that it may be an effective alternative 
therapy for somatic and urogenital symptoms of menopause. 
Soy isoflavones can also improve mood, vasomotor and other symptoms of menopause 
(Chedraui et al., 2010; Vitolins et al., 2010). Some authors have demonstrated the effects of 
soy isoflavones on of immune and oxidative stress markers in postmenopausal women 
(Ryan-Borchers et al, 2006). 
The use of isoflavones also can be beneficial for postmenopausal women suffering from 
insomnia. In a study on postmenopausal women who took isoflavones for four months, 
Hachul et al. (2010) found a decrease in the intensity and number of hot flashes and reduced 
symptoms of insomnia (data confirmed by increased sleep efficiency, which was observed in 
a polysomnographic analysis). 
5.1.2 Soy isoflavones and heart disease 
Current guidelines recommend diet as the most effective way to prevent dyslipidemias, and 
some studies indicate that a plant-based diet is more effective in increasing blood lipid 
levels. The American Diabetes Association considers that a plant-based diet is healthful, 
nutritionally adequate, and may provide health benefits for the prevention and treatment of 
certain diseases (Ferdowsian & Barnard, 2009; Craig & Mangels, 2009). 
Numerous epidemiological studies suggest that the regular ingestion of flavonoids can 
reduce the risk of many pathological conditions such as hypertension, diabetes, coronary 
heart disease, stroke and dementia (Ghosh & Schhepens, 2009).  Sagara et al. (2004) observed 
significant reductions in systolic and diastolic blood pressure, total cholesterol and non-high 
density lipoprotein cholesterol (non-HDL-C) in a group treated with a daily diet of 20 g of 
soy protein and 80 mg of isoflavones. In their review, Taku et al. (2010) reported that a daily 
ingestion of 25-375 mg of soy isoflavones (aglycone equivalents) for 2-24 weeks significantly 
decreased systolic blood pressure by 1.92 mmHg compared with placebo in adults with 
normal blood pressure and prehypertension.  
The main objective in the treatment of heart diseases with isoflavones is to decrease LDL-c 
because it is the most common cardiac risk factor (Nagarajan, 2010).  
Soybean-based diets have been reported to prevent cardiac events such as atherosclerosis. 
This condition is traditionally associated with obesity, insulin resistance, diabetes, 
dyslipidemia and inflammatory processes. The latter condition is considered the main factor 
for the initiation and progression of atherosclerosis. Dyslipidemia by itself is a primary risk 
factor for cardiovascular disease, peripheral vascular disease, and stroke. Soy-based diets 
can decrease all these risk factors because of their protein and flavonoids content (Jenkins et 
al., 2002; Kreijkamp-Kaspers et al., 2004; Sacks et al., 2006; Abumweis & Jone, 2008; Wong et 
al., 2010; Nagarajan, 2010; Shukla et al., 2010). 
Many studies have shown that isoflavones only affect the lipid profile when consumed in 
the presence of soy protein. Greaves et al. (1999) showed that monkeys responded to 
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isoflavonoids only if they also received soy protein. Probably these proteins facilitate the 
transport of isoflavonoids in the blood or their entry into target organs such as liver or 
muscle cells (Mikkola et al., 2003; Nikander et al., 2004).  
Hyperglycemia is implicated in many vascular complications because it is related to 
oxidative stress and endothelial dysfunction. Soy isoflavones (genistein and daidzein) can 
protect the cells against hydrogen peroxide-induced apoptosis and promote inhibition of 
cell proliferation due to oxidative stress (Xu et al., 2009). 
Although isoflavone activity has been linked to atheroprotective effects, it has been 
increasingly accepted that isoflavones may activate other nuclear receptors regulating lipid 
metabolism, such as liver x receptor, farnesoid x receptor and peroxisome proliferator-
activated receptors (PPARs). PPARs, which are members of the nuclear hormone receptor 
superfamily of ligand-activated transcription factors, regulate the expression of target genes 
involved in several physiological processes such as lipid catabolism. This explains their 
hypolipidemic effects and glucose because they increase insulin sensitivity. This would be 
useful in the treatment of type 2 diabetes (Ricketts et al., 2005; Carrara et al., 2009). 
5.1.3 Soy Isoflavones and bones 
Osteoporosis involves the reduction of bone mass, leading to enhanced bone fragility and 
increased risk of fractures. This condition can affect postmenopausal women because the 
ovaries stop producing estrogens. The treatment for osteoporosis is long and therapeutics 
may also causeside effects (Bitto et al., 2010). 
Osteoporosis is a skeletal disorder that predisposes to fractures. Postmenopausal women are 
susceptible to this condition because they go through a rapid phase of bone loss. This is 
preceded by declining concentrations of circulating estrogen, which plays an important role 
in maintaining the integrity of bone density by regulating bone formation and resorption. 
The intake of soybean isoflavones can help prevent the symptoms caused by loss of 
estrogen. Asian women are at lower risk of osteoporosis than Western women, which can be 
explained by the soybean-rich diet in Asian countries (Setchell & Cassidy, 1999; Nilsson & 
Gustafsson, 2002; Bawa, 2010).  
The use of soybeans or isoflavone supplement foods may increase bone mass. The intake of 
genistein aglycone stimulates osteoblast and inhibits osteoclast function, preventing bone 
loss, and daidzein has been shown to increase bone mass in postmenopausal women. Soy 
isoflavone extract supplements increase lumbar spine bone mineral density in menopausal 
women (Kreijkamp-Kaspers et al., 2004; Bitto et al., 2010; Taku et al., 2010; Hooshmand et 
al., 2010; Bawa, 2010).  Yamori et al. (2002) studied forty healthy female postmenopausal 
Japanese immigrants living in Brazil and found that urinary excretion of bone resorption 
markers was reduced in the isoflavone-treated group (37.3 mg per day for 10 weeks), while 
the placebo group showed no significant reduction. Differences in levels of urinary 
isoflavones and bone resorption markers between the two groups were significant.  
In addition, studies have shown that soy can also be applied clinically to substitute calcium 
phosphate cements on bone regeneration. Perut et al. (2010) describe the osteoblastic 
response to injectable bone cement based on a composite formulation including bioactive 
soybean and gelatin foaming agents. They took advantage of the foam-forming capacity of 
defatted soybean and gelatin gels to establish porosity and aid in osteoblast adhesion and 
growth, suggesting that the use of this bioactive compound can help bone regeneration 
through less invasive surgery. 
www.intechopen.com
 
Soybean: Food or Remedy? 
 
419 
5.1.4 Soy isoflavones and cancer 
Many studies have suggested that the use of soybeans in the regular diet can reduce levels 
of different cancers (Mateos-Aparicio et al., 2008; Liss et al., 2010).  The consumption of 
soybeans can prevent prostate cancer through the anti-androgenic effects of isoflavones 
(Liss et al., 2010). 
Oncology research has focused much attention on genistein (isoflavones found in soy and 
soy products) because it exerts a wide range of biological effects. Several epidemiological 
studies suggest that genistein is able to inhibit growth of primary tumors, which is the 
critical first step in the progression of metastatic disease. It can inhibit the development of 
metastatic disease in a variety of cancer types and inhibit cellular proliferation. It also 
increases the rate of cancer cell death, called apoptosis, and decreases the rate of cancer cell 
migration, which is important in the metastatic cascade (Pavese et al., 2010).  
The use of soy isoflavones and its benefits for women with breast cancer has become a 
subject of public consensus. Dong & Qin (2011) observed that the consumption of soy 
isoflavones is associated with a significantly reduced risk of breast cancer incidence in Asian 
populations and is inversely associated with risk of breast cancer recurrence. Kang et al. 
(2010) reported that the intake of soy isoflavones is related to a lower risk of recurrence 
among postmenopausal breast cancer patients.  
Soybean intake may be related to lower risk of developing breast cancer due to the presence 
of genistein (Cho et al., 2010). This isoflavone is a tyrosine kinase inhibitor and agonist of 
estrogen receptor-┚, which is known to have antitumor properties. Lattrich et al. (2010) 
showed that genistein can enhance the antitumor activity of trastuzumab (a common 
therapy for women with breast cancer whose tumors have excessive HER2 protein) in breast 
cancer cells in vitro.  
Genistein also may exert cytotoxic activity against breast cancer cells. This mechanism 
possibly involves mobilization of endogenous copper, whose levels are considerably 
increased in many types of cancers. Ullah et al. (2010) showed that this isoflavone can target 
endogenous copper, leading to prooxidant signaling and consequent cell death. The authors 
of this study attribute the anticancer effect of genistein to its preferential cytotoxicity 
towards cancer cells. 
In addition to the above, the antioxidant and anti-inflammatory effects of genistein can 
protect normal tissues from the adverse effects of chemotherapy and radiation and can be 
helpful in ameliorating the side effects of chemotherapy (Tacyildiz et al., 2010).  
5.1.5 Soy isoflavones and blood pressure 
Arterial hypertension is related to vascular disease and death.  Nevertheless, some factors 
are associated with the improvement of this condition. Soy products can reduce blood 
pressure. Longitudinal and clinical studies have shown that soy protein and isoflavones 
play an important role in diastolic blood pressure. The following mechanisms may explain 
the effects of soy protein and isoflavones on blood pressure: 1) improvement of systemic 
arterial compliance, 2) a natriuretic effect similar to the commonly used drug furosemide, 3) 
amino acid composition, and 4) lower salt retention. Soy protein and isoflavones also 
increase nitric oxide levels. This substance plays an effective role in regulating blood 
pressure and its increase is associated with the reduction of blood pressure via vasodilatory 
effects (Gimenez et al., 1998; Woodman et al., 2002; Nyby et al., 2004; Yang et al., 2005; 
Hermann et al., 2006; Taku et al., 2007; Azadbakht et al., 2007; Simão et al., 2010; Galleano et 
al., 2010).  
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6. Soy-derived phosphatidylserine and memory function 
A gradual decline in cognitive function is very common with aging. Many neurochemical 
substances are associated with functional neuronal membrane and memory. Alterations in 
these substances and in their mechanisms of action are related to a decline in cognitive 
functions. Many studies have demonstrated the important role of phosphatidylserine in 
reducing and reversing age-related neurochemical damage in non-demented people with 
memory impairment and in some diseases (Ritcher et al., 2010). 
Phosphatidylserine, an abundant phospholipid in the brain, can be extracted from bovine 
cortex to help improve the cognitive function of the elderly, including Alzheimer’s patients. 
However, the use of bovine cortex may be unfeasible due to the minuscule quantity 
obtained from each animal and the risk of bovine spongiform encephalopathy.  This fact 
emphasizes the importance of soy-derived phosphatidylserine (soybeans are used to 
produce soy-derived phosphatidylserine, which is produced from lecithin by an enzymatic 
reaction with L-serine). Kato-Kataoka et al. (2010) reported improvements in 
neuropsychological test scores and in memory ability in their test subjects treated with 
phosphatidylserine. These subjects were 50 to 69-year-old Japanese men and women 
suffering from subjective memory impairment. After six months of treatment, the authors 
found that soy-derived phosphatidylserine is a safety food ingredient that can improve 
memory functions in the elderly with impaired memory and can be useful as a supplement 
to prevent the development of dementia in men and women suffering from memory 
impairment (Amaducci, 1988; Zanotti et al., 1989; Engel et al., 1992; Vakhapova et al., 2010; 
Kato-Kataoka et al., 2010). 
7. Conclusions 
Soybeans represent an alternative food that is easy to consume while simultaneously 
possessing functional properties. They can be used as additives in new food products such 
as soy protein concentrates and soy protein isolates, soy milk, yogurt and tofu, grist, 
soybean flour, breads, crackers, cookies, breakfast cereals, diet supplements and textured 
soy protein used in meat products.  
Furthermore, soy can be used as a functional food. It has an important protective effect 
against many chronic diseases because of its content of bioactive components, whose 
characteristics are beneficial for nutritional physiology and metabolism.  Soy protein, 
isoflavones (phytoestrogens), non-digestible carbohydrates, and omega polyunsaturated 
fatty acids have gained considerable attention for their potential role in reducing the risk 
factors for cardiovascular disease, the incidence of certain cancers, inflammatory diseases, 
diabetes, osteoporosis and other disorders attributed to modern life styles and food habits, 
which have been confirmed by epidemiological and clinical studies. 
In view of the above, it can be concluded that soybeans have multiple effects on human 
health and well-being, both as food and as remedy. 
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